(Q42069689)

16 October 2017

title

Droperidol versus haloperidol for chemical restraint of agitated and combative patients (English)

1 reference

16 October 2017

1 reference

Thomas H Jr

1

1 reference

16 October 2017

Schwartz E

series ordinal

2

1 reference

16 October 2017

Petrilli R

series ordinal

3

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 April 1992

1 reference

Annals of Emergency Medicine

16 October 2017

published in

1 reference

16 October 2017

volume

21

1 reference

16 October 2017

issue

4

1 reference

16 October 2017

page(s)

407-413

1 reference

Rapid tranquilization of the violent patient

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Haloperidol for sedation of disruptive emergency patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Absorption, Metabolism and Excretion of Droperidol by Human Subjects Folloiwing Intramuscular and Intravenous Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Droperidol in the management of psychiatric emergencies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Droperidol in acutely agitated patients. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Plasma level profile of haloperidol in man following intramuscular administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

High-dose neuroleptics for acute brain failure after intensive chemotherapy for acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Cardiovascular safety of rapid treatment with intramuscular haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Haloperidol in obstetrics. A clinical trial in 350 women in labour.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Acute high-dose parenteral haloperidol treatment of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

A fatality during haloperidol treatment: mechanism of sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Neuroleptic malignant syndrome induced by a single injection of haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Haloperidol-induced torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

Cardiac arrhythmia and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2982660-5

7 January 2021

10.1016/S0196-0644(05)82660-5

Identifiers

DOI

1 reference

16 October 2017

1 reference